GABRA1

The GABRA1 gene encodes the alpha-1 subunit of the GABA-A receptor, a critical component of the brain's primary inhibitory signaling system that helps regulate neuronal excitability. 

Mutations in GABRA1 are associated with various forms of epilepsy, ranging from generalized epilepsy to severe developmental and epileptic encephalopathies.

What is GABRA1 (Gamma-Aminobutyric Acid Type A Receptor Subunit Alpha1)?

The GABRA1 gene provides instructions for making the alpha-1 (α1) subunit of the GABA-A receptor, one of the brain's most important tools for calming down nerve cells. 

When the neurotransmitter gamma-aminobutyric acid (GABA) activates this receptor, negatively charged chloride ions flow into neurons. This flow of chloride helps reduce brain cell activity, preventing overstimulation.

GABA-A receptors are essential for controlling the balance between brain excitation and inhibition, which is necessary for normal brain function and seizure prevention. GABRA1 mutations are often associated with various forms of epilepsy.

GABRA1: A Key Component of GABA-A Receptors

The GABA-A receptor is a protein complex composed of five subunits, typically arranged as two alpha (α), two beta (β), and one gamma (γ) subunit. 

Among these, the α1 subunit, encoded by the GABRA1 gene, is the most common alpha subunit in the human brain. 

GABA-A receptors play a vital role in fast inhibitory neurotransmission, helping to maintain balance in the brain's electrical activity. 

When the neurotransmitter GABA binds to the receptor, it opens a central pore that allows chloride ions to enter the neuron, making it less likely to fire. This process is key to calming overactive neurons. 

In newborns, however, the flow of chloride ions can briefly move in the opposite direction—out of the neuron—which actually promotes excitability and supports brain development. After infancy, the direction of chloride flow reverses, reinforcing the receptor's inhibitory role in the mature brain.

What Do Specific GABRA1 Mutations Mean?

Mutations in the GABRA1 gene can disrupt normal receptor function in different ways. 

Some pathogenic variants reduce the receptor's expression on the cell surface, meaning fewer GABA-A receptors are available to regulate brain activity. Others alter the receptor's behavior, causing it to open or close too slowly or quickly. 

One of the most well-known mutations is Ala322Asp (A322D), which has been identified in families with Juvenile Myoclonic Epilepsy (JME).

Genotype-Phenotype Correlation

The severity of clinical symptoms often depends on the type and location of the mutation. 

Milder mutations tend to be associated with typical generalized epilepsy. In contrast, more severe mutations, particularly those affecting the receptor’s membrane-spanning regions, are more likely to cause developmental and epileptic encephalopathy (DEE), a more serious condition. 

Even among individuals with the same mutation, there can be significant differences in the type and severity of seizures, known as variable expressivity.

When is GABRA1 Genetic Testing Relevant?

GABRA1 testing is important when a genetic cause of epilepsy is suspected, especially in these situations:

Genetic Generalized Epilepsies (GGEs)

GABRA1 mutations have been found in conditions like:

• Juvenile Myoclonic Epilepsy (JME)
• Childhood Absence Epilepsy

Developmental and Epileptic Encephalopathies (DEEs)

More severe conditions are marked by:

• Early-onset seizures
• Developmental delays
• Frequent or drug-resistant seizures

Clues That Suggest GABRA1 Testing

• Specific seizure types: Absence seizures, myoclonic jerks, generalized tonic-clonic seizures
• Family history of epilepsy
• Developmental delay combined with epilepsy
• Early age of onset (infancy or early childhood)

Inheritance Patterns

Many GABRA1-related epilepsies are autosomal dominant; however, some cases arise from de novo mutations (meaning they are not inherited).

Differential Diagnosis

Testing helps separate genetic epilepsies from seizures caused by brain injuries, infections, or metabolic disorders.

Test Procedure and Interpretation

Testing for GABRA1 is performed as a genetic test to look for mutations in the gene that would alter functional protein availability. The following section outlines the testing procedures and interpretation.

Testing Procedure and Preparation

Genetic testing involves blood, saliva, or cheek swab samples, although specialized laboratories may recommend different sample types. 

A cheek swab or saliva sample is easily obtained from the comfort of home, while blood samples typically require a blood draw.

Normal Reference Ranges

Normal reference ranges for GABRA1 genetic testing are considered to be without mutations that can alter the activity of the GABRA1 proteins.

Clinical Implications of Positive GABRA1 Mutations

The clinical implications of a positive GABRA1 mutation test result will vary by individual. However, GABRA1 mutations in symptomatic patients may signal a need for further assessment and possibly treatment, especially in the setting of epileptic symptoms.

Patients or practitioners with questions about the clinical implications of GABRA1 mutations should seek further assessment with a genetic counselor or expert. 

What Does the Absence of Pathogenic GABRA1 Variants Mean?

A negative result on GABRA1 genetic testing does not rule out a genetic cause of epilepsy. Many other genes may be involved in epilepsy syndromes. 

Additionally, non-genetic causes—including structural brain abnormalities, metabolic disorders, or infections—should also be considered when evaluating a patient with epilepsy, especially if genetic testing does not identify a pathogenic variant.

Order Genetic Testing

Click here to compare genetic test panels and order genetic testing for health-related SNPs.